A comparison of intrathecal 0.5% hyperbaric ropivacaine with 0.5% hyperbaric bupivacaine for elective surgery: a prospective, randomized, double-blind, controlled study


  • Pallavi Amol Kharat Department of Anaesthesia, Hinduhridaysamrat Balasaheb Thackeray Medical College and Dr. R N Cooper Hospital, Juhu, Mumbai, Maharashtra, India
  • Rajshree Chandrashekhar Deopujari Departmet of Anaethesia, Jaslok Hospital and Research Centre, Pedder road, Mumbai, Maharashtra, India




Prospective, Randomized, Hyperbaric, Intrathecal


Background: To compare the onset of action, intensity and duration of motor block of 0.5% hyperbaric ropivacaine with 0.5% hyperbaric bupivacaine for elective lower abdominal, perineal and lower-limb surgeries.

Methods: 70 patients undergoing elective lower abdominal, perineal and lower limb surgery receiving spinal anesthesia were divided randomly into two groups, Group B, (bupivacaine 5 mg/ml with glucose 80 mg/ml;4 ml, and Group R, (ropivacaine 5 mg/ml with glucose 80 mg/ml; 4 ml).

Results: The results were analyzed and compared using Chi-square test, student ‘s t-test and Fisher’s exact tests. The onset of sensory block was more rapid with bupivacaine (p<0.05). The maximum cephalad spread was similar in both groups. However, the time required to maximum extent of cephalic spread was less in Group B (p<0.05). Motor block 3 according to modified bromage scale was obtained in both groups and the time to achieve the same was not significant. The duration of motor blockade i.e., time to complete regression of motor block was significantly greater with Group B than with Group R (0.0001). We found that there was no significant difference in the time taken to achieve grade 3 motor block but ropivacaine gave a lesser degree of motor block which regressed faster than bupivacaine (118 min versus 156 min; p<0.0001). There was no significant difference in hemodynamic parameters except that diastolic and mean pressures remained on lower side in group B (p<0.05).

Conclusions: We conclude that 0.5% hyperbaric ropivacaine provides a sensory block of similar onset and extent, shorter duration of action and less frequency of hypotension as compared to 0.5% hyperbaric bupivacaine.


Hampl KF, Schneider MC, ummenhofer W, Drewe J. Transient Neurologic Symptoms After Spinal Anesthesia. Anesth Analg. 1995;81:1148-53.

Schneider M, Ettlin T, Kaufman M.. Tranient Neurological Toxicity after Hyperbaric Subarachnoid Anesthesia with 5% Lidocaine. Anesth Analg. 1993;76:1154-7.

Pollock JE, Neal JM, Stephenson RN, Wiley CE. Prospective Study of the Incidence of Transient Radicular Iirritation in Patients Undergoing Spinal Anesthesia. Anesthesiology. 1991;84:1361-7.

Freedman JM, Li KD, Drasner K. Transient Neurologic Symptoms after Spinal anesthesia. Anesthesiology. 1998;89:633-41.

Hodgson PS, Neal JM, Pollock JE and Liu SS. The Neurotoxicity of Drugs given Intrathecally (Spinal). Anesth Analg. 1999;88:797-809.

Whiteside JB, Burke D and Wildsmith JAW. Comparison of ropivacaine 0.5% (in glucose 5%) with bupivacaine 0.5% (in glucose 8%) for spinal anesthesia for elective surgery. Br J Anaesth. 2003;90:304-8.

Whiteside JB, Burke D and Wildsmith JAW. Spinal anesthesia with ropivacaine 5 mg ml-1 in glucose 10mg ml-1 0r 50 mg ml-1. Br J Anaesth. 2001;86:241-4.

McDonald SB, Liu SS, Kopacz DJ, Stephenson CA. Hyperbaric spinal Ropivacaine. A comparison to Bupivacaine in volunteers. Anesthesiology. 1999;90:971-7.

Chung CJ, Choi SR, Yeo KH. Hyperbaric Spinal Ropivacaine for Cesarean Delivery: A Comparison to Hyperbaric bupivacaine. Anesth. 2007;19(2):385-387.

Scott DB, Lee A, Fagan D. Acute Toxicity of Ropivacaine Compared with that of Bupivacaine. Anesth Analg. 1989;69:563-9.

Gautier PE, Kock MD, Steenberge AV. Intrathecal Ropivacaine for Ambulatory surgery. Anesthesiology. 1999;91:1239-45.

Malinovsky JM, Charles F, Kick O. Intrathecal anesthesia: Ropivacaine versus Bupivacaine.

McNamee DA, Parks L, McClelland AM et al. Intrathecal ropivacaine for total hip arthroplasty: double-blind comparative study with isobaric 7.5 mg ml-1 and 10 mg ml-1 solutions. Br J Anaesth. 2001;87:743-7.

Kallio H, Snall EVT, Kero PM. A Comparison of Intrathecal Plain Solutions Containing Ropivacaine 20 or 15 mg Versus Bupivacaine 10 mg. Anesth Analg. 2004;99:713-7.

Botzug N, Bigat Z, Karsli B. Comparison of ropivacaine and bupivacaine for intrathecal anesthesia during outpatient arthroscopic surgery. Journal of Clinical Anesthesia. 2006;18:521-5.

Bannister J, McClure JH, Wlidsmith JAW. Effect of glucose concentration on the intrathecal spread of 0.5% bupivacaine. Br J Anaesth. 1990;64:232-4.

Moller IW, Fernandes A and Edstrom HH. Subarachnoid anaesthesia with 0.5% bupivacaine: Effects of density. Br J Anaesth. 1984;56:1191-94.

Lee.A, Ray D, Littlewood DG and Wildsmith JAW. Effect of dextrose concentration on the intrathecal spread of amethocaine. Br J Anaesth. 1988;61:135-38.

Sanderson P, Read J, Littlewood DG. Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread. Br J Anaesth. 1994;73:744-46.

Kleef JW, Veering BT and Burm AGL. Spinal Anesthesia with Ropivacaine: A Double-Blind Study on the Efficacy and Safety of 0.5% and 0.75% Solutions in Patients Undergoing Minor Lower Limb Surgery. Anesth Analg. 78:1125-30.

Carvalho AC, Machado JA, and Nociti JR. Spinal anesthesia with 0.5% hyperbaric ropivacaine and 0.5% hyperbaric bupivacaine: A comparative study. Rev Bras Anestesiol. 2002;6:659-65.

Hocking G and Wildsmith JAW. Intrathecal drug spread. Br J Anaesth. 2004;93:568-78.

Greene NM. Distribution of Local Anesthetic Solutions within the Subarachnoid Space. Anesth Analg. 1985;64:715-30.

Simpson D, Curran MP, Oldfield V. Ropivacaine: A review of its use in regional anesthesia and acute pain management. Drugs. 2005;65(18):2675-2717.

Robert K. Stoelting. Local Anesthetics. In: Pharmacology and Physiology in Anesthetic Practice. 4th edn. R. Craig Percy (eds); Lippincott- Raven Publishers. Philadelphia. 2006;179-207.

G. McLeod. Spinal Anesthesia- Intradural & Extradural. In: Lee’s Synopsis 13th edition. NJH Davis, JN Cashman (eds); Butterworth Heinemann Limited Singapore. 2006;471-536.

Whiteside JB and Wildsmith JAW. Developments in local anesthetic drugs. Br J Anaesth. 2001;87:27-35.

Zaric D, Nydahl PA, Philipson L. The effects of continuous epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) and 0.25% bupivacaine on sensory and motor blockade in volunteers: a double-blind study. Reg Anesth. 1996;21:14-25.

Krudsen K, Beckman-Suurkula M, Blomberg S. Central nervous and Cardiovascular effects of i.v infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507-14.

Yamashita A, Matsumoto M, Matsumoto S. A Comparison of the Neurotoxic Effects on the Spinal Cord of Tetracaine, Lidocaine, Bupivacaine, and Ropivacaine administered Intrathecally in Rabbits. Anesth Analg. 2003;97:512-9.

Kristensen JD, Karlsten R, and Torsten G. Spinal cord blood flow after Intrathecal injection of Ropivacaine: A screening for Neurotoxic effects. Anesth Analg. 1996;82:636-40.

Fettes PDW, Hocking G, Peterson MK. Comparison of plain and hyperbaric solutions of ropivacaine for spinal anaesthesia. Br J Anaesth. 2005;94:107-111.

Levin A, Datta S, and Camann WR. Intrathecal Ropivacaine for labor analgesia: A comparison with bupivacaine. Anesth Analg. 1998;87:624-7.

Khaw KS, Ngan Kee WD, Wong ELY. Spinal Ropivacaine for cesarean section. Anesthesiology. 2001;95:1346-50.

Khaw KS, Ngan Kee WD, Wong M. Spinal Ropivacaine for Cesarean Delivery: A comparison of Hyperbaric and Plain solutions. Anesth Analg. 2002;94:680-5.

Buckenmaier CC, Neilsen KC, Pietroborn R. Small-dose Intrathecal Lidocaine versus Ropivacaine for anorectal surgery in an ambulatory setting. Anesth Analg. 2002;95:1253-7.

Casati A, Moizo E, Marchetti C, and Vinciguerra F. A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, and levobupivacaine for inguinal herniorraphy. Anesth Analg. 2004;99:1387-92.

Cappelleri G, Aldegheri G, Danelli G. Spinal anesthesia with hyperbaric levobupivacaine and ropivacaine for outpatient knee arthroscopy: A prospective, randomized, double-blind study. Anesth Analg. 2005;101:77-82.

Sanli S, Yegin A, Kayacan N. Effects of hyperbaric spinal ropivacaine for cesarean section with or without fentanyl. European Journal of Anaesthesiology. 2005;22:457-61.

Eid EA, AlSaif F. Plain versus hyperbaric ropivacaine for spinal anesthesia in cirrhotic patients undergoing ano-rectal surgery. AJAIC. 2004;10:11-18.

Marron-Pena M, Rivera-Flores J. Revista Mexicana de Anestesiologia. 2008;31:133-38.




How to Cite

Kharat, P. A., & Deopujari, R. C. (2021). A comparison of intrathecal 0.5% hyperbaric ropivacaine with 0.5% hyperbaric bupivacaine for elective surgery: a prospective, randomized, double-blind, controlled study. International Journal of Research in Medical Sciences, 9(2), 471–478. https://doi.org/10.18203/2320-6012.ijrms20210426



Original Research Articles